| Product Code: ETC7419031 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guyana Neuroimaging Market Overview |
3.1 Guyana Country Macro Economic Indicators |
3.2 Guyana Neuroimaging Market Revenues & Volume, 2021 & 2031F |
3.3 Guyana Neuroimaging Market - Industry Life Cycle |
3.4 Guyana Neuroimaging Market - Porter's Five Forces |
3.5 Guyana Neuroimaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Guyana Neuroimaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Guyana Neuroimaging Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Guyana Neuroimaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Guyana |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of neurological conditions |
4.2.3 Technological advancements in neuroimaging techniques and equipment |
4.3 Market Restraints |
4.3.1 Limited access to advanced neuroimaging facilities in remote areas of Guyana |
4.3.2 High cost associated with neuroimaging procedures for patients |
4.3.3 Lack of skilled healthcare professionals specializing in neuroimaging |
5 Guyana Neuroimaging Market Trends |
6 Guyana Neuroimaging Market, By Types |
6.1 Guyana Neuroimaging Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Guyana Neuroimaging Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Guyana Neuroimaging Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.1.4 Guyana Neuroimaging Market Revenues & Volume, By Computed Tomography (CT), 2021- 2031F |
6.1.5 Guyana Neuroimaging Market Revenues & Volume, By Positron Emission Tomography (PET), 2021- 2031F |
6.1.6 Guyana Neuroimaging Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021- 2031F |
6.1.7 Guyana Neuroimaging Market Revenues & Volume, By Functional Magnetic Resonance Imaging (fMRI), 2021- 2031F |
6.1.8 Guyana Neuroimaging Market Revenues & Volume, By Diffusion Tensor Imaging (DTI), 2021- 2031F |
6.1.9 Guyana Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Guyana Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Guyana Neuroimaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Guyana Neuroimaging Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.3 Guyana Neuroimaging Market Revenues & Volume, By Psychiatric Disorders, 2021- 2031F |
6.2.4 Guyana Neuroimaging Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.3 Guyana Neuroimaging Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Guyana Neuroimaging Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Guyana Neuroimaging Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 Guyana Neuroimaging Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.5 Guyana Neuroimaging Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.6 Guyana Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
7 Guyana Neuroimaging Market Import-Export Trade Statistics |
7.1 Guyana Neuroimaging Market Export to Major Countries |
7.2 Guyana Neuroimaging Market Imports from Major Countries |
8 Guyana Neuroimaging Market Key Performance Indicators |
8.1 Average waiting time for neuroimaging services |
8.2 Number of facilities offering neuroimaging services in Guyana |
8.3 Percentage of population covered by health insurance that includes neuroimaging services |
9 Guyana Neuroimaging Market - Opportunity Assessment |
9.1 Guyana Neuroimaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Guyana Neuroimaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Guyana Neuroimaging Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Guyana Neuroimaging Market - Competitive Landscape |
10.1 Guyana Neuroimaging Market Revenue Share, By Companies, 2024 |
10.2 Guyana Neuroimaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here